Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: A Single Center Retrospective Analysis

NCT05617352 is registered in ClinicalTrials.gov with Yongtao Han as lead sponsor.

NCT NCT05617352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05617352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: A Single Center Retrospective Analysis
Lead sponsor
Yongtao Han
Phase
Observational
Overall status
Completed
Start date
May 1, 2022
Completion date
October 10, 2022
Enrollment
1,659 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer